AI & Machine Learning

Following a string of 14 acquisitions, IMS Legal Strategies is sold. The deal highlights major trends in private equity and the future of legal services.

Amid a severe specialist shortage, a new digital platform is empowering Arizona's frontline doctors to provide faster mental health care for kids and new moms.

Fintech firm Pagaya's latest AAA-rated deal attracts new investors, signaling strong confidence in its AI-driven lending model despite economic headwinds.

Decoy Therapeutics touts a revolutionary AI platform for multi-virus drugs, but faces financial hurdles. An upcoming investor event could define its future.

Enlyte's acquisition of PartsTrader signals a major shift in the auto claims industry, promising more efficiency but raising questions about competition.

The indoor air quality giant launches its roadshow, seeking to pay down debt and capitalize on soaring demand for healthier buildings and AI infrastructure.

An expanded partnership aims to move businesses from AI experimentation to autonomous operations, tackling the critical 'last-mile problem' of value realization.

Boston's Bio-IT World conference shifts from AI theory to execution, showcasing how the life sciences industry is now deploying AI to accelerate new therapies.

With new CEO Stan Lequin and private equity backing, Fidus Systems is pivoting to infuse AI into embedded design, signaling a new era of growth and M&A.

Metazoa's new Intelligent Assistant for Salesforce goes beyond diagnostics, promising to actively help admins and developers remediate org complexity.

Amid financial headwinds, radiation therapy firm Accuray appoints a proven sales leader to spearhead a critical commercial transformation.

Hundreds of thousands of U.S.-born children live in exile after parental deportation. A new initiative aims to restore their rights and build a path home.

Digital health leader Bunny Ellerin joins Aegis Ventures as Chief Ecosystem Officer, a strategic move to fuel AI-native innovation through network power.

With record revenue and A-list fans, British MedTech firm LYMA is doubling down on the US market, blending clinical data with celebrity appeal.

New preclinical data for ATNM-400 and Actimab-A shows promise for treating resistant solid tumors and AML, highlighting a new frontier in cancer therapy.

A key summit will dissect Vietnam's plan to navigate US tariffs and Mideast conflict while pursuing its ambitious goal of becoming a high-income nation.

MTI replaces its Road Tour with an intense, invite-only forum, uniting top regulators and experts to find the next wave of healthcare solutions.

Despite risks from Mideast conflict, the ASEAN+3 region's 4% growth forecast is backed by deep internal trade and a shift away from global dependence.

The ASEAN+3 region projects 4.0% growth but faces a severe energy shock. A new report reveals how a structural shift toward internal demand may be its shield.

As 80% of Indian firms lag in DPDP readiness, Cross Identity offers its ₹50 lakh AI compliance platform at zero cost to accelerate adoption.